The Sherwin-Williams Company
The Sherwin-Williams Company (0L5V.L) Financial Performance & Income Statement Overview
Review The Sherwin-Williams Company (0L5V.L) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
The Sherwin-Williams Company (0L5V.L) Income Statement & Financial Overview
Explore comprehensive income reports for The Sherwin-Williams Company 0L5V.L, broken down by year and quarter.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $5.31B | $5.30B | $6.16B | $6.27B |
Cost of Revenue | $2.75B | $2.72B | $3.13B | $3.21B |
Gross Profit | $2.56B | $2.57B | $3.03B | $3.06B |
Gross Profit Ratio | $0.48 | $0.49 | $0.49 | $0.49 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $1.80B | $1.88B | $1.89B | $1.85B |
Operating Expenses | $1.80B | $1.88B | $3.03B | $1.83B |
Total Costs & Expenses | $4.54B | $4.61B | $5.03B | $5.04B |
Interest Income | -$600000.00 | -$1.40M | $2.60M | $900000.00 |
Interest Expense | $103.80M | $98.50M | $107.00M | $115.20M |
Depreciation & Amortization | $153.20M | $161.90M | $155.60M | $153.30M |
EBITDA | $917.70M | $876.00M | $1.29B | $1.39B |
EBITDA Ratio | $0.17 | $0.17 | $0.21 | $0.22 |
Operating Income | $765.30M | $673.50M | $1.13B | $1.23B |
Operating Income Ratio | $0.14 | $0.13 | $0.18 | $0.20 |
Other Income/Expenses (Net) | -$112.30M | -$57.90M | -$108.30M | -$58.40M |
Income Before Tax | $653.00M | $615.60M | $1.02B | $1.17B |
Income Before Tax Ratio | $0.12 | $0.12 | $0.17 | $0.19 |
Income Tax Expense | $149.10M | $135.50M | $216.60M | $283.50M |
Net Income | $503.90M | $480.10M | $806.20M | $889.90M |
Net Income Ratio | $0.09 | $0.09 | $0.13 | $0.14 |
EPS | $2.02 | $1.92 | $3.22 | $3.55 |
Diluted EPS | $2.00 | $1.90 | $3.18 | $3.50 |
Weighted Avg Shares Outstanding | $249.40M | $252.68M | $250.60M | $251.00M |
Weighted Avg Shares Outstanding (Diluted) | $252.50M | $254.10M | $253.90M | $254.20M |
Over the past four quarters, The Sherwin-Williams Company demonstrated steady revenue growth, increasing from $6.27B in Q2 2024 to $5.31B in Q1 2025. Operating income reached $765.30M in Q1 2025, maintaining a consistent 14% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $917.70M, reflecting operational efficiency. Net income rose to $503.90M, with EPS at $2.02. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan